Brinker Capital Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Brinker Capital Investments's BMY Position: Q1 2026 in Review
Brinker Capital Investments reduced its Bristol-Myers Squibb (BMY) stake by 5.8% in Q1 2026, selling an estimated $235K and leaving 64,960 shares worth $3.94M. The position accounts for 0.03% of the portfolio, ranked #445.
Brinker Capital Investments first reported a position in BMY in Q3 2015 and has held it in 37 quarters since. The position peaked at $7.86M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Brinker Capital Investments held 64,960 shares of Bristol-Myers Squibb worth $3.94M as of Q1 2026.
- Brinker Capital Investments sold 4,030 Bristol-Myers Squibb shares in Q1 2026, an estimated $235K.
- Bristol-Myers Squibb made up 0.03% of Brinker Capital Investments's portfolio in Q1 2026, its #445 holding.
- Brinker Capital Investments first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 37 quarters since.
- Brinker Capital Investments's Bristol-Myers Squibb position peaked at $7.86M in Q2 2022.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.